What began as a $500 million verdict in five plaintiffs’ favors in 2016 and was later cut to $151 million has now been reduced to nothing. At the same time, Johnson & Johnson – once on the losing side of a significant decision in a bellwether trial over its DePuy division’s Pinnacle hip implants – can take a case out of the “loss” column for now.
The verdict came as the ...
continue reading...